Mark Duncan, MD
Personal Statement
I have pursued a career at the intersection of mental health and primary care, training in both family medicine and addiction psychiatry. I currently practice in various integrated care settings as a consulting psychiatrist and in the outpatient adult psychiatry clinic. I am the co-medical director for the University of Washington Psychiatry and Addiction Case Conference (UW PACC), a weekly online learning collaborative to help community providers across the state improve their psychiatric and addiction clinical skills. My area of interest is focused on improving addiction and psychiatric treatment to primary care settings. I also spend a significant amount of time training both family medicine and psychiatry trainees and fellows on integrated treatments for substance use disorders.Education
Rush University Medical education, 2006
West Suburban Medical Center Residency, Family Medicine
University of Washington - School of Medicine Residency, Psychiatry
University of Washington - School of Medicine Fellowship, Addiction Psychiatry
Department Affiliations
Scholarly Expertise
- Addiction
- Addiction psychiatry/psychology
- Alcohol Use Disorder (AUD)
- Collaborative Care / Integrated Care
- Harm reduction
- Measurement-based care
- Medically complex
- Medication management
- Opioid Use Disorder (OUD)
- Outpatient psychiatry/psychology
- Primary care
- Telemedicine
- Telepsychiatry/psychology
- Telepsychiatry/telepsychology
- Training
Clinical Expertise
Substance use treatment integration in primary care settings; substance use in underserved populations.
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Improving opioid use disorder treatment using contingency management via mHealth
- Collaborating to Heal Addiction and Mental Health in Primary Care (CHAMP)
Recent Publications
Collaborating to heal addiction and mental health in primary care (CHAMP): A protocol for a hybrid type 2a trial.
(2024 Nov)
Contemp Clin Trials 146(): 107700
Fortney JC, Ratzliff AD, Blanchard BE, Ferro L, Rouvere J, Chase E, Duncan MH, Merrill JO, Simpson T, Williams EC, Austin EJ, Curran GM, Schoenbaum M, Heagerty PJ, Saxon AJ
(2024 Nov)
Contemp Clin Trials 146(): 107700
Fortney JC, Ratzliff AD, Blanchard BE, Ferro L, Rouvere J, Chase E, Duncan MH, Merrill JO, Simpson T, Williams EC, Austin EJ, Curran GM, Schoenbaum M, Heagerty PJ, Saxon AJ
Safer-use strategies in the context of harm-reduction treatment for people experiencing homelessness and alcohol use disorder.
(2024 Jul)
Int J Drug Policy 129(): 104448
Alawadhi YT, Shinagawa E, Taylor EM, Jackson C, Fragasso A, Howard M, Fan L, Kolpikova E, Karra S, Frohe T, Clifasefi SL, Duncan MH, Collins SE
(2024 Jul)
Int J Drug Policy 129(): 104448
Alawadhi YT, Shinagawa E, Taylor EM, Jackson C, Fragasso A, Howard M, Fan L, Kolpikova E, Karra S, Frohe T, Clifasefi SL, Duncan MH, Collins SE
Project ECHO in Psychiatric Workforce Development: the Example of a Perinatal Mental Health ECHO.
(2024 Jun)
Acad Psychiatry 48(3): 249-253
Ramaraj AB, Franz NA, Bhat A, Adachi J, Quiray JA, Bespalova N, Duncan MH, Cowley DS
(2024 Jun)
Acad Psychiatry 48(3): 249-253
Ramaraj AB, Franz NA, Bhat A, Adachi J, Quiray JA, Bespalova N, Duncan MH, Cowley DS
Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?
(2023 Oct)
Ann Intern Med 176(10): 1431-1433
Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ
(2023 Oct)
Ann Intern Med 176(10): 1431-1433
Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ
Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study.
(2023 Jul 6)
JMIR Form Res 7(): e47516
Hallgren KA, Duncan MH, Iles-Shih MD, Cohn EB, McCabe CJ, Chang YM, Saxon AJ
(2023 Jul 6)
JMIR Form Res 7(): e47516
Hallgren KA, Duncan MH, Iles-Shih MD, Cohn EB, McCabe CJ, Chang YM, Saxon AJ
Show complete publication list »